Terms ending in 2035
Musc Foundation for Research Development
Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,118,903 | Aminotriazole-Based KDM1A Inhibitors as Epigenetic Modulators Grace period ended Nov 6, 2026 · lapse expected · Low confidence | Musc Foundation for Research Development | Grace period ended Nov 6, 2026 lapse expected | Low confidence | |
| US 9,889,018 | Expandable Vertebral Body Replacement Device and Method In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 12,239,545 | Expandable Vertebral Body Replacement Device and Method In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 10,653,530 | Expandable Vertebral Body Replacement Device and Method In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US D892,325 | Insulated Tissue Forceps In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 9,775,719 | Expandable Vertebral Body Replacement Device and Method In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 10,428,331 | Targeted Nanocarriers for the Administration of Immunosuppressive Agents In force · High confidence | Musc Foundation for Research Development | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.